MGAM and Congenital myasthenic syndromes: Treatment-refractory ophthalmoparesis/plegia among particularly the prepubertal group of juveniles with AChR-Ab negative MG or MuSK-Ab negative MG, may raise the possibility of a congenital myasthenic syndrome (CMS).